Guide for Authors
NeuroToxicology specializes in publishing the best peer-reviewed original research papers
dealing with the effects of toxic substances on the nervous system of humans and experimental animals of all ages. The Journal emphasizes
papers dealing with the neurotoxic effects of environmentally significant chemical hazards, manufactured drugs and naturally occurring
compounds. Papers dealing with the effects of neurotoxicants on other systems (e.g. reproductive, endocrine, immune) or processes (e.g.
metabolic) are also welcome.
NeuroToxicology recognizes the diverse backgrounds and interests of scientists who work in these
areas and encourages the participation of all. Areas of special emphasis and interest -- both basic and applied -- have been identified;
they include: neuropathology, neurophysiology, neurochemistry, neuropharmacology, neurology, behavioral toxicology, development neurotoxicology,
psychiatry, toxicology, epidemiology, psychology, neuroteratology, behavioral teratology, risk assessment and regulatory issues. Papers
reporting interdisciplinary studies are especially welcome. Papers reporting any effects of known neurotoxicants are welcome.
Types of paper
NeuroToxicology will publish papers containing Original Research, Brief Communications,
Reviews, Letters to the Editor, Teaching Monographs, Forum "Position Papers," Commentaries, Book Reviews, and Features. Periodically,
the Journal will also publish Announcements, Abstracts and Proceedings of Meetings.
Original Research.
Articles will
contain laboratory or clinical scientific research pertaining to neurotoxicology. Economy of style is encouraged, although papers may
be as long as short as the findings justify. Illustrations should make significant points. Excessive or repetitive illustrations will
not be published.
Brief Communications. NeuroToxicology will publish brief reports of work that has progressed to
the stage at which it is considered that the science of neurotoxicology would be advanced if the results were made available as soon
as possible. These reports should be no longer than six pages in the present format of
NeuroToxicology. Authors should submit
reports of this category of publication only when they believe that the rapid world-wide communication of the results is of the utmost
importance to other investigators.
Reviews.
Review papers will summarize and critically analyze topics of current
interest in neurotoxicology. Authors should keep in mind the diverse backgrounds of the readers of this interdisciplinary Journal.
Letters
to the Editor.
Letters to the Editor may be up to 500 words in length, responding to material in
NeuroToxicology, introducing
a new point of view, or discussing a topic of current concern. Letters will be subject to the same review process as Original Research
articles and Reviews. Any letter responding to a previous publication may be submitted to the author of the original paper in order that
any reply may be published simultaneously with the letter. Letters should be received within two months of mailing of the Journal.
Teaching
Monographs.
The format and length of monographs will be the prerogative of the author. The subject matter should be of broad
interest due to the diverse backgrounds of the readership. The contents should be aimed at the level of a senior graduate student in
neurosciences or toxicology. Teaching illustrations are encouraged.
Forum.
The Forum section "Position Papers" of
the Journal will address, discuss, and present position papers on current issues in neurotoxicology. Replies will be invited from all
sectors of society; they include: chemical industries, pharmaceutical industries, governmental regulatory agencies, other governmental
groups, academic institutions, as well as consumers and special interest groups. The format will be flexible. Letters responding to a
position paper in the Forum section will be submitted to the author of the position paper in order that any reply may be published simultaneously
with the Letter. Letters should be received within two months of mailing of the Journal.
Announcements, Abstracts, Proceedings.
NeuroToxicology will accept for publication announcements, abstracts, or capsulized proceedings of meetings, symposia or other matters
of interest to the subscriber of
NeuroToxicology.
Page charges
This journal has
no page charges.
Ethics in publishing
For
information on Ethics in publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics
and
http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All authors
are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with
other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived
to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
NeuroToxicology requires full
disclosure of all potential conflicts of interest. At the end of the manuscript text (and in the cover letter of the manuscript), under
a subheading "Conflict of Interest statement", all authors must disclose any financial and personal relationships with other people or
organisations that could inappropriately influence (bias) their work. If there are no conflicts of interest, the authors should state,
"The authors declare that there are no conflicts of interest." Signed copies of the
NeuroToxicology Conflict of Interest policy
form are required upon submission. The Conflict of Interest policy form can be downloaded
here. In order to minimize delays, we strongly advise that the signed copies of these statements are prepared
before you submit your manuscript. The corresponding author is responsible for sharing this document with all co-authors. Each and every
co-author must sign an individual disclosure form. The corresponding author is responsible for uploading their form and those of their
co-authors.
Submission declaration and verification
Submission of an article implies that
the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic
thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or
explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in
the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To
verify originality, your article may be checked by the originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the
authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove
an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript
and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail,
fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded
by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers
will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until
authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or
rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained
author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested
to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe
the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report;
and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier
has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply
with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements
and policies please visit
http://www.elsevier.com/fundingbodies.
US National Institutes of Health (NIH) voluntary
posting (" Public Access") policy.
Elsevier facilitates author response to the NIH voluntary posting request (referred to
as the NIH "Public Access Policy"; see
http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's
manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier
of acceptance, we will ask you to confirm via e-mail (by e-mailing us at
NIHauthorrequest@elsevier.com) that your work
has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing.
Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review
comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy.
There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.
Open access
This journal offers you the option of making your article freely available to all via the ScienceDirect
platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been
accepted for publication. The fee of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions
and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements
are available at
http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this
option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf). Whatever
access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article
on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language
and language services
Please write your text in good English (American or British usage is accepted, but not a mixture
of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit
http://webshop.elsevier.com/languageservices or our customer support
site at
http://support.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally online and
you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single
PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted
to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence,
including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Subdivision - numbered sections
Divide your article into clearly
defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in
section numbering). Use this numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given
a brief heading. Each heading should appear on its own separate line.
Introduction
State
the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published
should be indicated by a reference: only relevant modifications should be described.
Results
Results
should be clear and concise.
Discussion
This should explore the significance of the results
of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion
of published literature.
Conclusions
The main conclusions of the study may be presented
in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
Essential title page information
•
Title.
Concise and informative. Titles are often used
in information-retrieval systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses
(where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name
and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle
correspondence at all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country
and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date
by the corresponding author.
•
Present/permanent address.
If an author has moved since the work described
in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to
that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript
Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is
required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is
often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if
essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they
must be defined at their first mention in the abstract itself.
Graphical abstract
A Graphical
abstract is optional and should summarize the contents of the article in a concise, pictorial form designed to capture the attention
of a wide readership online. Authors must provide images that clearly represent the work described in the article. Graphical abstracts
should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 ×
1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution
of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images also in accordance
with all technical requirements:
Illustration
Service.
Highlights
Highlights are a short collection of bullet points that
convey the core findings of the article. Highlights are optional and should be submitted in a separate file in the online submission
system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet
point). See
http://www.elsevier.com/highlights for examples.
Keywords
Immediately
after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts
(avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible.
These keywords will be used for indexing purposes.
Acknowledgements
Collate acknowledgements
in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote
to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing
assistance or proof reading the article, etc.).
Nomenclature and units
Nomenclature.
For styling of isotope, enzyme, and biochemical nomenclature, consult the Information for Authors of the Archives of Biochemistry and
Biophysics.
Units and Abbreviations.
Units will be in general accordance with the International System (SI) as adopted
by the 11th General Conference on Weights and Measures. Note that the abbreviations for a unit are never followed by a full stop, e.g.
10glL, 5 pmpl, 2mM. Do not use full stops in abbreviations with capital letters, e.g. DNA. For case abbreviations use full stops, e.g.
i.v.,s.c. All other words to be abbreviated should be written in full when they appear in the text and be followed by the abbreviation
in parentheses.
Database linking
Elsevier aims at connecting online articles with external
databases which are useful in their respective research communities. If your article contains relevant unique identifiers or accession
numbers (bioinformatics) linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases,
then please indicate those entities according to the standard explained below.
Authors should explicitly mention the
database
abbreviation (as mentioned below) together with the actual database number, bearing in mind that an error in a letter or number
can result in a dead link in the online version of the article.
Please use the following format:
Database ID: xxxx
Links
can be provided in your online article to the following databases (examples of citations are given in parentheses):
•
ASTM:
ASTM Standards Database (ASTM ID: G63)
•
CCDC: Cambridge Crystallographic
Data Centre (CCDC ID: AI631510)
•
GenBank: Genetic sequence
database at the National Center for Biotechnology Information (NCBI) (GenBank ID: BA123456)
•
GEO:
Gene Expression Omnibus (GEO ID: GSE27196; GEO ID: GPL5366; GEO ID: GSM9853)
•
MI:
EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
•
MINT:
Molecular INTeractions database (MINT ID: 6166710)
•
NCBI Taxonomy:
NCBI Taxonomy Browser (NCBI Taxonomy ID: 48184)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
PDB: Worldwide Protein Data
Bank (PDB ID: 1TUP)
•
TAIR: The Arabidopsis Information Resource
database (TAIR ID: AT1G01020)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Math formulae
Present simple formulae in the line of
normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle,
variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations
that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes
should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build
footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and
present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table
footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your
original artwork.
• Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in
your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
•
Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images
near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic
artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this
site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when
your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements
for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text
as 'graphics'.
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings:
use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If
your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please
do not:
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files)
and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure,
at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether
or not these illustrations are reproduced in color in the printed version.
For color reproduction in print, you will receive information
regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or
on the Web only. For further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version
should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the
figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep text in
the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number
tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them
with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables
do not duplicate results described elsewhere in the article.
References
Citation
in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any
references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference
list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference
style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'.
Citation of a reference as 'in press' implies that the item has been accepted for publication.
Web references
As
a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author
names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the
reference list) under a different heading if desired, or can be included in the reference list.
References
in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations
in the text) to other articles in the same Special Issue.
Reference management software
This
journal has standard templates available in key reference management packages EndNote (
http://www.endnote.com/support/enstyles.asp)
and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only
need to select the appropriate journal template when preparing their article and the list of references and citations to these will be
formatted according to the journal style which is described below.
Reference style
Text:
All citations in the text should refer to:
1.
Single author: the author's name (without initials, unless there is ambiguity)
and the year of publication;
2.
Two authors: both authors' names and the year of publication;
3.
Three or more authors:
first author's name followed by 'et al.' and the year of publication.
Citations may be made directly (or parenthetically). Groups
of references should be listed first alphabetically, then chronologically.
Examples: 'as demonstrated in wheat (Allan, 2000a, 2000b,
1999; Allan and Jones, 1999). Kramer et al. (2010) have recently shown ....'
List: References should be arranged first alphabetically
and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified
by the letters 'a', 'b', 'c', etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2010;163:51–9.
Reference
to a book:
Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.
Reference to a chapter in an edited
book:
Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to
the electronic age. New York: E-Publishing Inc; 2009. p. 281–304.
Note shortened form for last page number. e.g., 51–9,
and that for more than 6 authors the first 6 should be listed followed by "et al." For further details you are referred to "Uniform Requirements
for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927–34) (see also
http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video data
Elsevier
accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files
that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done
in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed.
All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your
video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum
size of 50 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web
products, including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose
any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the
link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier
accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional
possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files
supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data
in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply
a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
The following list will be useful during the final checking of an article prior to sending
it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following
items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded, and contain:
•
Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
•
Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
•
All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use
of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color
reproduction on the Web (free of charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white
in print
• If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at
http://support.elsevier.com.
Use of the Digital
Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists
of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication.
The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they
have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from
a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL
hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One
set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper
proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now
provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available
free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the proofs (also given online).
The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If
you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail,
or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor.
We will do everything possible to get your article published quickly and accurately – please let us have all your corrections within
48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying,
as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed
with the publication of your article if no response is received.
Offprints
The corresponding
author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via
the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked version of the published
article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
To
Obtain Permissions to Reproduce or Back Issues of NeuroToxicology from Volume 1 (1979) to Volume 21 (2000): contact
Copyright Clearance Center (CCC)
online www.copyright.com or write to 222 Rosewood Drive, Danvers, MA,
01923,
or call 978-750-8400
or fax 978-646-8600.
For
inquiries relating to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details
for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can
track accepted articles at
http://www.elsevier.com/trackarticle. You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ)
and/or contact Customer Support via
http://support.elsevier.com.
